Antineoplastic Agents
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent in fringement and its liability is at buyer's risk.
| Product Name |
CAS NO. |
Documentation |
| Antineoplastic Agents
|
| 5-Fluorouracil |
51-21-8 |
GMP,DMF,COS,FDA |
| Anastrozole |
120511-73-1 |
GMP,DMF |
| Amifostine |
20537-88-6 |
GMP is applying |
| Bendamustine Hcl |
3543-75-7;97832-05-8 |
GMP,DMF |
| Capecitabine |
154361-50-9 |
GMP,DMF,CEP |
| Carboplatin |
41575-94-4 |
GMP,DMF,CEP |
| Carmustine |
154-93-8 |
GMP |
| Cisplatin |
15663-27-1 |
GMP,DMF,COS |
| Dacarbazine |
4342-03-4 |
GMP,DMF,COS,CEP |
| Docetaxel Anhydrous |
114977-28-5 |
GMP,DMF |
| Erlotinib HCl |
183319-69-9 |
GMP,DMF |
| Etoposide |
33419-42-0 |
GMP,DMF,COS |
| Fludarabine Phosphate |
75607-67-9 |
DMF,COS,FDA |
| Gemcitabine Hydrochloride |
122111-03-9 |
GMP,DMF,COS |
| Granisetron Hydrochloride |
107007-99-8 |
GMP,DMF,COS,FDA |
3|39